Assisted Reproductive Technology (ART) Market, Revenue Share, Key Growth Trends, Key Players and Forecast, 2020-2030 – Business Merseyside

the Assisted Reproductive Technologies (ART) Market The size is expected to reach USD 39.12 billion in 2030 and register a CAGR of 7.4% during the forecast period, according to the latest report from Reports and Data. Rising demand for surrogacy by the LGBTQIA+ community and increasing success rates of in vitro fertilization (IVF) and related ART procedures are driving the market revenue growth.

Infertility can be treated with ART. ART helps treat infertility by providing a variety of procedures that a patient can choose from depending on their needs and medical history. The most popular and effective type of ART is in vitro fertilization (IVF). Donor eggs, donor sperm or frozen embryos are popular services used by ART patients. Surrogacy is a major driver of market growth as more and more people move beyond the social stigma associated with it and focus on the benefits it provides.

Multiple gestation or multiple pregnancies are a major constraint to the ART market as they are considered a great risk to the health of the patient and the infant. The Centers for Disease Control (CDC) reported that while ART accounts for 17% of twins born to couples, the risk of multiple pregnancies during ART procedures is 27 times higher than those who conceive naturally. This factor is restraining the growth of the market.

Get a sample report @

The report provides a panoramic view of the market and insights that will help in formulating better business decisions. Moreover, the study helps companies and well-established players to better understand the market and make informed decisions. The report also examines in detail the main factors influencing the growth of the market.

Major companies operating in the market include:

Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (USA), Vitroife AB (Sweden), Thermo Fisher Scientific (USA), Celmatix, Inc. (USA), Anecova (Switzerland) , OvaScience (USA), Ferring Pharmaceuticals (USA), and FertiPro NV (Belgium).

The report covers an in-depth analysis of key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government agreements, product launches and brand promotions, among others .

Ask for a discount on the report @

The report aims to provide a better understanding of market dynamics and industry functioning on a global level. To better understand the industry, the global Assisted Reproductive Technology (ART) market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. The report also offers country-wise analysis to provide crucial information about market size, market growth, market revenue growth, and economic growth in each region.

Based on the types of products and applications offered by the Assisted Reproductive Technology (ART) industry, the market is segmented into:

Type Technology Outlook (Revenue, USD Billion; 2019-2030)

  • Artificial insemination
  • surrogate mother
  • Induction of ovulation
  • Others

Procedural Outlook (Revenue, USD Billion; 2019-2030)

  • fresh donor
  • Fresh non-donor
  • Donor Frozen
  • Non-donor frozen
  • Embryo/egg bank
  • Others

Procedural Technology Outlook (Revenue, USD Billion; 2019-2030)

  • In vitro fertilization
    • IVF with intracytoplasmic sperm injection (ICSI)
    • IVF without ICSI
  • Artificial insemination-Intrauterine insemination
  • Replacement of frozen embryos
  • Others

End-Use Outlook (Revenue, USD Billion; 2019-2030)

  • Fertility clinics
  • Hospitals
  • Clinical research
  • Others

The regional analysis covers:

  • North America
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • The rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
  • Middle East and Africa
    • Saudi Arabia
    • EA
    • South Africa
    • Rest of MEA

To learn more about the report @

Benefits of Assisted Reproductive Technology (ART) Market Report:

  • Panoramic overview of opportunities and risks in the assisted reproductive technologies (ART) sector
  • Study of recent innovations and developments in the industry
  • In-depth study of growth pattern of Assisted Reproductive Technology (ART) industry
  • In-depth assessment of the competitive landscape of major players in the Assisted Reproductive Technology (ART) industry
  • Assisted Reproductive Technology (ART) Market Drivers, Restraints, and Opportunities Analysis
  • Evaluation of technological developments and latest industry trends

Request Report Customization @

Thank you for reading our report. For customization or additional request, please contact us. Our team will ensure that the report is tailored to your needs.

Browse more related reports:

Cochlear Implants Market @

Dry Mouth Relief Market @

Epinephrine Market @

In Vitro Lung Models Market @

Organ-on-Chip Market @

About reports and data

Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries and helping customers make a smarter business decision. We offer market intelligence research ensuring relevant, fact-based research across multiple sectors including healthcare, technology, chemicals, power and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts from a variety of areas of expertise.

Contact us:

Jean W

Business Development Manager

Reports and Data | The Web:

Direct line: +1-212-710-1370

Email: [email protected]

Back To Top